Bausch + Lomb Q4 revenue up 11% CC; FY GAAP loss widens; guides 2025 revenue ~$5B

Bausch & Lomb Corp

2024-FY EPS reported -$0.90 revenue$4,791,000,000

Q4 revenue $1.28B, up 9% reported and 11% constant currency, with growth across all segments.
FY GAAP net loss attributable $317M vs $260M loss in 2023; adjusted net income $204M vs $258M.
Adjusted EBITDA ex Acquired IPR&D FY $878M (+$140M); Q4 $259M (+$28M).
2025 guidance: revenue $4.95B-$5.05B (~5.5%-7.5% CC growth); Adj. EBITDA $900M-$950M; FX headwinds ~$100M revenue.
Dry eye portfolio approaching $1B annual revenue; contact lens double-digit Q4 growth; XIIDRA/MIEBO driving pharma.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.